Research Paper Volume 16, Issue 3 pp 2563—2590
Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors
Figure 4. Protein expression analysis of TPX2 in the HPA database. (A) TPX2 was detected in nucleoplasm, cytokinetic bridge and mitotic spindle. (B) Immunofluorescence staining of the subcellular localization of TPX2 in RH-30 and U-2 OS tumor cells. (C) Representative immunohistochemical staining of TPX2 in normal and tumor tissues of different cancer types.